Reza Fathi

This inventor holds 43 USPTO granted patents and 10 published patent applications and 7 EPO patents, primarily in Infectious Disease Treatment. Top assignees: Redhill Biopharma Ltd., Xtl Biopharmaceuticals Ltd., Vivoquest, Inc.. Active years: 2004-2026.

USPTO Granted Patents = 43 (Patent Applications = 10)

% Patents Active = 79.1

EPO Patents = 7 (Patent Applications = 5)

Average Co-Inventor Count = 3.0

ph-index = 5

Forward Citations = 79(Granted Patents)

Location History:

Hohokus, NJ (US) (2004 - 2019)
Raleigh, NC (US) (2019 - 2021)
Oradell, NJ (US) (2016 - 2024)

Company Filing History:

34 out of 43

Redhill Biopharma Ltd.

patents

6 out of 8

Xtl Biopharmaceuticals Ltd.

Redhill Bipharma Ltd.

patent

Years Active: 2004-2026

Loading Chart...

Areas of Expertise:

Coronavirus Infection

Helicobacter Pylori

Cancer Treatment

Sphingosine Kinase Inhibitor

Serine Protease Inhibitor

Triple Antibiotic

Ebola Treatment

Colonic Evacuation

Irritable Bowel Syndrome

Autoimmune Disease

Antiemetic Formulations

Pyrazole Compounds

43 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12569475 - Method for eradicating helicobacter pylori infection in patients regardless of body mass index (2026-03-10),

2. 12551469 - Sphingosine kinase 2 inhibitor for treating coronavirus infection (2026-02-17),

3. 12502381 - Serine protease inhibitor for treating coronavirus infection (2025-12-23),

4. 12370206 - Therapy for inhibition of single-stranded RNA virus replication (2025-07-29),

5. 12115150 - Biomarkers of coronavirus pneumonia (2024-10-15),

6. 11931463 - All-in-one fixed-dose combination for treatinginfection (2024-03-19),

7. 11918560 - Serine protease inhibitor for treating coronavirus infection (2024-03-05),

8. 11878011 - Method for eradicatinginfection in patients regardless of body mass index (2024-01-23),

9. 11786541 - Inhibitor of sphingosine kinase 2 for treating Ebola (2023-10-17),

10. 11633385 - Combination compositions for treatment of cancer (2023-04-25),

11. 11590154 - Triple antibiotic fixed-dose combination products, dosing regimen, methods, and kits for treating pulmonary non-tuberculosis mycobacterial infections (2023-02-28),

12. 11471448 - Sphingosine kinase 2 inhibitor for treating coronavirus infection in moderately severe patients with pneumonia (2022-10-18),

13. 11364227 - Sphingosine kinase 2 inhibitor for treating coronavirus infection (2022-06-21),

14. 11135172 - Rifabutin-based compositions and methods for treatinginfection (2021-10-05),

15. 11090325 - Compositions for treating ebola virus infection (2021-08-17),

Title: The Innovative Journey of Reza Fathi

Introduction: Reza Fathi, a talented inventor hailing from Oradell, NJ (US), has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents: Reza Fathi's latest patents include a cutting-edge software application for enhancing cybersecurity measures in cloud computing systems and a revolutionary design for a solar-powered mobile device charger.

Career Highlights: With a career spanning over two decades, Reza Fathi has worked with renowned tech companies, leading research institutions, and universities to develop cutting-edge solutions in the areas of artificial intelligence, renewable energy, and data security.

Collaborations: Throughout his career, Reza Fathi has collaborated with top engineers, scientists, and researchers to bring his innovative ideas to life. His collaborative projects have resulted in patented inventions that have reshaped the technological landscape.

Conclusion: Reza Fathi's passion for innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of technology. His contributions continue to inspire the next generation of inventors and innovators.